Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of dermatology (Print)

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/1346-8138.14222PMID 29352483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lineage Tracing

  2020cited by this paper
• Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells.

  2017cited by this paper
• Type XVII collagen coordinates proliferation in the interfollicular epidermis

  2017cited by this paper
• TANGO1 assembles into rings around COPII coats at ER exit sites

  2017cited by this paper
• Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes.

  2017cited by this paper
• Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model

  2017cited by this paper
• Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn

  2017cited by this paper
• Revertant mosaicism in genodermatoses

  2017cited by this paper
• Regeneration of the entire human epidermis using transgenic stem cells

  2017cited by this paper
• Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.

  2016cited by this paper
• Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis

  2016cited by this paper
• Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa

  2016cited by this paper
• Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression.

  2016cited by this paper
• Fate by Chance, not by Choice: Epidermal Stem Cells Go Live.

  2016cited by this paper
• Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.

  2016cited by this paper
• Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options.

  2016cited by this paper
• Epidermolysis Bullosa Acquisita Develops in Dominant Dystrophic Epidermolysis Bullosa.

  2016cited by this paper
• Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma

  2016cited by this paper
• Intracellular mechanisms of molecular recognition and sorting for transport of large extracellular matrix molecules

  2016cited by this paper
• Collagen VII Half-Life at the Dermal-Epidermal Junction Zone: Implications for Mechanisms and Therapy of Genodermatoses.

  2016cited by this paper
• Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.

  2015cited by this paper
• Dystrophic epidermolysis bullosa: a review

  2015cited by this paper
• Stem cell heterogeneity and plasticity in epithelia.

  2015cited by this paper
• TANGO1 recruits ERGIC membranes to the endoplasmic reticulum for procollagen export

  2015cited by this paper
• An active role for basement membrane assembly and modification in tissue sculpting

  2015cited by this paper
• Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses.

  2015cited by this paper
• The pathway of collagen secretion.

  2015cited by this paper
• Epidermal barriers.

  2014cited by this paper
• Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification.

  2014cited by this paper
• SLY1 and Syntaxin 18 specify a distinct pathway for procollagen VII export from the endoplasmic reticulum

  2014cited by this paper
• Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa

  2014cited by this paper
• Extracellular matrix assembly: a multiscale deconstruction

  2014cited by this paper
• Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa.

  2014cited by this paper
• Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes

  2014cited by this paper
• Local and global dynamics of the basement membrane during branching morphogenesis require protease activity and actomyosin contractility.

  2014cited by this paper
• Mammalian skin cell biology: At the interface between laboratory and clinic

  2014cited by this paper
• Traversing the basement membrane in vivo: A diversity of strategies

  2014cited by this paper
• High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion

  2014cited by this paper
• Long-Term Stability and Safety of Transgenic Cultured Epidermal Stem Cells in Gene Therapy of Junctional Epidermolysis Bullosa

  2013cited by this paper
• Topical Application of Recombinant Type VII Collagen Incorporates Into the Dermal-Epidermal Junction and Promotes Wound Closure.

  2013cited by this paper
• Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure.

  2013cited by this paper
• Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa

  2013cited by this paper
• Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa

  2013cited by this paper
• Collagen VII plays a dual role in wound healing.

  2013cited by this paper
• Tumor type-dependent function of the par3 polarity protein in skin tumorigenesis.

  2012cited by this paper
• Cell-extracellular matrix interactions in normal and diseased skin.

  2011cited by this paper
• Hair follicle stem cells provide a functional niche for melanocyte stem cells.

  2011cited by this paper
• Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients.

  2011cited by this paper
• Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma

  2011cited by this paper
• PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia

  2011cited by this paper
• Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells

  2011cited by this paper
• The international dystrophic epidermolysis bullosa patient registry: An online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations

  2011cited by this paper
• Basement membranes: cell scaffoldings and signaling platforms.

  2011cited by this paper
• Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.

  2011cited by this paper
• Molecular Pathogenesis of Genetic and Inherited Diseases Keratinocyte-/ Fibroblast-Targeted Rescue of Col 7 a 1-Disrupted Mice and Generation of an Exact Dystrophic Epidermolysis Bullosa Model Using a Human COL 7 A 1 Mutation

  2010cited by this paper
• Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006

  2010cited by this paper
• Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.

  2010cited by this paper
• Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice

  2010cited by this paper
• Revertant mosaicism in recessive dystrophic epidermolysis bullosa.

  2010cited by this paper
• Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.

  2010cited by this paper
• Circulating IgA and IgE autoantibodies in antilaminin‐332 mucous membrane pemphigoid

  2010cited by this paper
• Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen

  2009cited by this paper
• TANGO1 facilitates cargo loading at endoplasmic reticulum exit sites.

  2009cited by this paper
• Possible involvement of basement membrane damage in skin photoaging.

  2009cited by this paper
• Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.

  2009cited by this paper
• Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.

  2009cited by this paper
• A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.

  2008cited by this paper
• Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy

  2008cited by this paper
• Characterization of Molecular Mechanisms Underlying Mutations in Dystrophic Epidermolysis Bullosa Using Site-directed Mutagenesis*

  2008cited by this paper
• Supramolecular Interactions in the Dermo-epidermal Junction Zone

  2008cited by this paper
• Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.

  2007cited by this paper
• Interactions between fibroblasts and keratinocytes in morphogenesis of dermal epidermal junction in a model of reconstructed skin.

  2006cited by this paper
• Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells

  2006cited by this paper
• Keratinocyte‐specific modulation of type VII collagen gene expression by pro‐inflammatory cytokines (tumor necrosis factor‐α and interleukin‐1β)

  2005cited by this paper
• Type VII Collagen Is Required for Ras-Driven Human Epidermal Tumorigenesis

  2005cited by this paper
• The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

  2004cited by this paper
• Notch1 functions as a tumor suppressor in mouse skin

  2003cited by this paper
• Transcriptional control of the mouse Col7a1 gene in keratinocytes: basal and transforming growth factor-beta regulated expression.

  2003cited by this paper
• Procollagen VII self-assembly depends on site-specific interactions and is promoted by cleavage of the NC2 domain with procollagen C-proteinase.

  2003cited by this paper
• Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa

  2002cited by this paper
• Development and Characterization of A Recombinant Truncated Type VII Collagen “Minigene”

  2000cited by this paper
• Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa.

  1999cited by this paper
• Transient bullous dermolysis of the newborn associated with compound heterozygosity for recessive and dominant COL7A1 mutations.

  1998cited by this paper
• Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-β*

  1998cited by this paper
• Most anchoring fibrils in human skin originate and terminate in the lamina densa.

  1997cited by this paper
• Laminin 5 Binds the NC-1 Domain of Type VII Collagen

  1997cited by this paper
• Interactions of the Amino-terminal Noncollagenous (NC1) Domain of Type VII Collagen with Extracellular Matrix Components

  1997cited by this paper
• Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion.

  1997cited by this paper
• Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain

  1995cited by this paper
• Cloning of human type VII collagen. Complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms.

  1994cited by this paper
• Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene.

  1994cited by this paper
• A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa

  1993cited by this paper
• A homozygous insertion–deletion in the type VII collagen gene (COL7A1) in Hallopeau–Siemens dystrophic epidermolysis bullosa

  1993cited by this paper
• Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.

  1993cited by this paper
• Immunoblotting studies of linear IgA disease.

  1993cited by this paper
• Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes.

  1992cited by this paper
• Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro

  1992cited by this paper
• Keratinocytes and fibroblasts from a patient with mutilating dystrophic epidermolysis bullosa synthesize drastically reduced amounts of collagen VII: lack of effect of transforming growth factor-beta.

  1992cited by this paper
• Transforming growth factor-beta up-regulates type VII collagen gene expression in normal and transformed epidermal keratinocytes in culture.

  1991cited by this paper
• Epithelial-mesenchymal interactions enhance expression of collagen VII in vitro.

  1990cited by this paper

• In vitro modelling of extracellular matrix changes during skin aging: from static 2D to 3D dynamic microphysiological systems

  2026cites this paper
• Extracellular matrix dysregulation in aging, calcification, and cancer diseases: insights into cellular senescence, inflammation, and novel therapeutic strategies

  2025cites this paper
• Basement membrane zone proteins in wound healing: Insights from epidermolysis bullosa models

  2025cites this paper
• Basement membranes at a glance

  2025cites this paper
• Gene editing for collagen disorders: current advances and future perspectives

  2025cites this paper
• Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec‐svdt (B‐VEC) in an Open‐Label Study of Japanese Subjects With Dystrophic Epidermolysis Bullosa

  2025cites this paper
• Extracellular Matrix Alterations in Inflammatory Skin Diseases: Emerging Biomarkers and Clinical implications.

  2025cites this paper
• Advanced phasing techniques in congenital skin diseases

  2024cites this paper
• Systemic treatment of recessive dystrophic epidermolysis bullosa with mesenchymal stromal cells: a scoping review of the literature and conclusions for future clinical research

  2024cites this paper
• Tissue memory relies on stem cell priming in distal undamaged areas

  2023cites this paper
• A case report of jejunum transplantation in the treatment of severe cervical esophageal stricture in patients with dystrophic epidermolysis bullosa

  2023cites this paper
• Lifelong tissue memory relies on spatially organised dedicated progenitors located distally from the injury

  2023cites this paper
• Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa.

  2022cites this paper
• Cas9‐guided haplotyping of three truncation variants in autosomal recessive disease

  2022cites this paper
• A de novo missense mutation in the NC1 domain of type VII collagen leads to dystrophic epidermolysis bullosa

  2022cites this paper
• Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges.

  2021cites this paper
• The pathogeneses of pemphigus and pemphigoid diseases.

  2021cites this paper
• Understanding collagen interactions and their targeted regulation by novel drugs

  2021cites this paper
• Laminin 332 in cancer: when the extracellular matrix turns signals from cell anchorage to cell movement.

  2020cites this paper
• The Human Epidermal Basement Membrane: A Shaped and Cell Instructive Platform That Aging Slowly Alters

  2020cites this paper
• Hair follicle stem cell progeny heal blisters while pausing skin development

  2020cites this paper
• Basement membrane collagens and disease mechanisms

  2019cites this paper
• Epidermolysis bullosa acquisita: A comprehensive review.

  2019cites this paper
• The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.

  2018cites this paper
• Life before and beyond blistering: The role of collagen XVII in epidermal physiology

  2018cites this paper